Description of Blood Analysis: 

The Hepatitis A Total and IgM combined panel is a comprehensive screening tool designed to clarify a person’s status regarding the Hepatitis A virus (HAV). The IgM component is a “current infection” marker, identifying an active or very recent illness. The Total Antibody test measures both IgM and IgG together. By looking at these two markers simultaneously, clinicians can determine whether a patient is currently sick, has completely recovered from a past infection, or has developed protection through vaccination. This dual approach eliminates ambiguity and provides a complete picture of the body’s immune relationship with the virus.

What does the analysis represent?

• Goal: To differentiate between an active infection and long-term immunity.
• Primary Application: Investigating symptoms of acute hepatitis, screening for immunity prior to travel or employment, and managing public health responses during outbreaks.
• Method: High-sensitivity Chemiluminescent Immunoassay (CLIA).

Recommendations for the Test (General)

• Time: Best performed in the morning.
• Fasting: Fasting is required for at least 8 hours before the test, preferably 12 hours.
• Rest: Stay relaxed and avoid smoking for at least 30 minutes before the blood draw.
• Specific Rules: Provide your physician with details regarding recent travel history or any Hepatitis A vaccinations you have received in the past.

What can affect the results?

• Factors Altering Levels: Recent vaccination (can trigger a temporary IgM rise); intravenous immunoglobulin therapy; or severe liver disease unrelated to HAV that might interfere with protein synthesis.

When to take the test?

• Recommendations: If you have symptoms such as dark urine, clay-colored stools, or jaundice; if you have been in close contact with someone diagnosed with Hepatitis A; or if you need to confirm your immunity status for medical or travel records.
• Preparation: No specialized preparation is required beyond the standard fasting protocol.

How to interpret the results?

The synthesis of these two distinct markers into a clinical diagnosis must be performed exclusively by a trained physician. The interplay between a positive “Total” result and a negative “IgM” result carries a completely different medical meaning than if both were positive. Only a doctor can navigate these permutations to decide if you are currently contagious, naturally immune, or if your results reflect a successful vaccination response. Professional oversight is mandatory to ensure that the diagnostic conclusions align with your specific clinical history.

Possible further investigations

• ALT, AST, and Bilirubin Panel: To measure the extent of current liver inflammation.
• Hepatitis B and C Panels: To rule out other viral causes of liver distress.
• Abdominal Ultrasound: To assess the physical condition of the liver and gallbladder.
• Consultation with an Infectious Disease Specialist: For guidance on recovery or vaccination planning.

When does the next step make sense? 

If the IgM is positive, the immediate next step is medical isolation and supportive care under a doctor’s supervision to prevent spreading the virus. If the Total antibody is negative, the next step should be a discussion about starting the Hepatitis A vaccine series. Always allow your healthcare provider to dictate the follow-up plan based on these findings.

👉 If necessary, you can discuss the results of the analysis with a specialist, such as an gastroenterologist (Doctors – TAMC).